Controlled & Modified Drug Release Summit 2022, March 1-2 Ossi Leppänen2022-04-06T18:40:49+02:00January 12th, 2022| Read More
Drug Delivery Company DelSiTech Ltd Announces Appointment of Mr. Martti Hedman to Its Board of Directors Ossi Leppänen2022-01-05T14:00:39+02:00January 5th, 2022| Read More
DelSiTech Awarded UnitaidExplore Funding for Innovations in Paediatric Healthcare Ossi Leppänen2021-10-04T13:00:04+02:00October 4th, 2021| Read More
Partnering Opportunities in Drug Delivery 2021, October 28-29 Ossi Leppänen2021-10-01T17:04:01+02:00October 1st, 2021| Read More
BIO-Europe Digital 2021, October 25-28 Ossi Leppänen2022-01-12T14:37:08+02:00September 17th, 2021| Read More
DelSiTech Announces an Exclusive Licensing and Collaboration Agreement with Visus Therapeutics for the Development of Long-acting Therapies in Ophthalmology Ossi Leppänen2021-08-19T14:00:03+02:00August 19th, 2021| Read More
